{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:29:13Z","timestamp":1786663753226,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02298-5","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:33:03Z","timestamp":1779373983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CorePAM: a 24-gene PAM50-derived expression score with cross-platform external validation for breast cancer prognosis"],"prefix":"10.1186","volume":"28","author":[{"given":"Rafael","family":"de Negreiros Botan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Batista","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"6797","key":"2298_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352. https:\/\/doi.org\/10.1038\/35021093.","journal-title":"Nature"},{"issue":"19","key":"2298_CR2","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869\u201374. https:\/\/doi.org\/10.1073\/pnas.191367098.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2298_CR3","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/jco.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27(8):1160\u20137. https:\/\/doi.org\/10.1200\/jco.2008.18.1370.","journal-title":"J Clin Oncol"},{"issue":"8","key":"2298_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso F, van\u2019t Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, et al. 70-gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med. 2016;375(8):717\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1602253.","journal-title":"N Engl J Med"},{"issue":"2","key":"2298_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018;379(2):111\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1804710.","journal-title":"N Engl J Med"},{"key":"2298_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1471-2407-14-177","volume":"14","author":"TO Nielsen","year":"2014","unstructured":"Nielsen TO, Balslev E, M\u00fcller S, Krogh M, Shak S, Cardoso F, et al. Analytical validation of the PAM50-based Prosigna breast cancer prognostic gene signature assay and nCounter analysis system using formalin-fixed paraffin-embedded breast tumor specimens. BMC Cancer. 2014;14:177. https:\/\/doi.org\/10.1186\/1471-2407-14-177.","journal-title":"BMC Cancer"},{"issue":"27","key":"2298_CR7","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/nejmoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817\u201326. https:\/\/doi.org\/10.1056\/nejmoa041588.","journal-title":"N Engl J Med"},{"issue":"6871","key":"2298_CR8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van\u2019t Veer","year":"2002","unstructured":"van\u2019t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530\u20136. https:\/\/doi.org\/10.1038\/415530a.","journal-title":"Nature"},{"issue":"1","key":"2298_CR9","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KGM Moons","year":"2015","unstructured":"Moons KGM, Altman DG, Reitsma JB, Ioannidis JPA, Macaskill P, Steyerberg EW, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1\u201373. https:\/\/doi.org\/10.7326\/M14-0698.","journal-title":"Ann Intern Med"},{"key":"2298_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2288-13-33","volume":"13","author":"P Royston","year":"2013","unstructured":"Royston P, Altman DG. External validation of a Cox prognostic model: principles and methods. BMC Med Res Methodol. 2013;13:33. https:\/\/doi.org\/10.1186\/1471-2288-13-33.","journal-title":"BMC Med Res Methodol"},{"key":"2298_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/po.17.00135","volume":"2","author":"C Brueffer","year":"2018","unstructured":"Brueffer C, Vallon-Christersson J, Grabau D, Ehinger A, H\u00e4kkinen J, Hegardt C, et al. Clinical value of RNA sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: a report from the population-based multicenter Sweden Cancerome Analysis Network - Breast initiative. JCO Precis Oncol. 2018;2:1\u201318. https:\/\/doi.org\/10.1200\/po.17.00135.","journal-title":"JCO Precis Oncol"},{"key":"2298_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-015-0131-9","volume":"7","author":"LH Saal","year":"2015","unstructured":"Saal LH, Vallon-Christersson J, H\u00e4kkinen J, Hegardt C, Grabau D, Winter C, et al. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. Genome Med. 2015;7:20. https:\/\/doi.org\/10.1186\/s13073-015-0131-9.","journal-title":"Genome Med"},{"issue":"7418","key":"2298_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"CGA Network","year":"2012","unstructured":"Network CGA. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370. https:\/\/doi.org\/10.1038\/nature11412.","journal-title":"Nature"},{"issue":"7403","key":"2298_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352. https:\/\/doi.org\/10.1038\/nature10983.","journal-title":"Nature"},{"key":"2298_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2407-11-143","volume":"11","author":"KJ Kao","year":"2011","unstructured":"Kao KJ, Chang KM, Hsu HC, Huang AT. Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer. 2011;11:143. https:\/\/doi.org\/10.1186\/1471-2407-11-143.","journal-title":"BMC Cancer"},{"issue":"6","key":"2298_CR16","doi-asserted-by":"publisher","first-page":"R953","DOI":"10.1186\/bcr1325","volume":"7","author":"Y Pawitan","year":"2005","unstructured":"Pawitan Y, Bj\u00f6hle J, Amler L, Borg \u00c5L, Egyhazi S, Hall P, et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005;7(6):R953\u201364. https:\/\/doi.org\/10.1186\/bcr1325.","journal-title":"Breast Cancer Res"},{"issue":"18","key":"2298_CR17","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1001\/jama.2011.593","volume":"305","author":"C Hatzis","year":"2011","unstructured":"Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, et al. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA. 2011;305(18):1873\u201381. https:\/\/doi.org\/10.1001\/jama.2011.593.","journal-title":"JAMA"},{"issue":"8","key":"2298_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.1665","volume":"28","author":"MAQC Consortium","year":"2010","unstructured":"MAQC Consortium. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol. 2010;28(8):827\u201338. https:\/\/doi.org\/10.1038\/nbt.1665.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2298_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1349-7006.2012.02231.x","volume":"103","author":"T Miyake","year":"2012","unstructured":"Miyake T, Nakayama T, Naoi Y, Yamamoto N, Otani Y, Kim SJ, et al. GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. Cancer Sci. 2012;103(5):913\u201320. https:\/\/doi.org\/10.1111\/j.1349-7006.2012.02231.x.","journal-title":"Cancer Sci"},{"issue":"3","key":"2298_CR20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10549-011-1895-2","volume":"132","author":"LJ Esserman","year":"2012","unstructured":"Esserman LJ, Berry DA, Cheang MCU, Yau C, Perou CM, Carey L, et al. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007\/150012; ACRIN 6657). Breast Cancer Res Treat. 2012;132(3):1049\u201362. https:\/\/doi.org\/10.1007\/s10549-011-1895-2.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"2298_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ccell.2022.05.005","volume":"40","author":"DM Wolf","year":"2022","unstructured":"Wolf DM, Yau C, Wulfkuhle J, Brown-Swigart L, Gallaher R, Hirst GL, et al. Redefining breast cancer subtypes to guide treatment prioritization and maximize response: predictive biomarkers across 10 cancer therapies. Cancer Cell. 2022;40(6):609-623.e6. https:\/\/doi.org\/10.1016\/j.ccell.2022.05.005.","journal-title":"Cancer Cell"},{"issue":"1","key":"2298_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616.","journal-title":"Bioinformatics"},{"issue":"2","key":"2298_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Ser B. 2005;67(2):301\u201320. https:\/\/doi.org\/10.1111\/j.1467-9868.2005.00503.x.","journal-title":"J R Stat Soc Ser B"},{"issue":"4","key":"2298_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385\u201395.","journal-title":"Stat Med"},{"issue":"1","key":"2298_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322. https:\/\/doi.org\/10.18637\/jss.v033.i01.","journal-title":"J Stat Softw"},{"issue":"5","key":"2298_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for Cox\u2019s proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1\u201313. https:\/\/doi.org\/10.18637\/jss.v039.i05.","journal-title":"J Stat Softw"},{"issue":"18","key":"2298_CR27","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell Jr","year":"1982","unstructured":"Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543\u20136. https:\/\/doi.org\/10.1001\/jama.1982.03320430047030.","journal-title":"JAMA"},{"issue":"10","key":"2298_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/sim.4154","volume":"30","author":"H Uno","year":"2011","unstructured":"Uno H, Cai T, Pencina MJ, D\u2019Agostino RB, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011;30(10):1105\u201317. https:\/\/doi.org\/10.1002\/sim.4154.","journal-title":"Stat Med"},{"issue":"30","key":"2298_CR29","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381\u201397. https:\/\/doi.org\/10.1002\/sim.5958.","journal-title":"Stat Med"},{"issue":"3","key":"2298_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515\u201326. https:\/\/doi.org\/10.1093\/biomet\/81.3.515.","journal-title":"Biometrika"},{"issue":"446","key":"2298_CR31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144.","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"2298_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"issue":"3","key":"2298_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1\u201348. https:\/\/doi.org\/10.18637\/jss.v036.i03.","journal-title":"J Stat Softw"},{"issue":"7414","key":"2298_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"issue":"24","key":"2298_CR35","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1002\/sim.1009","volume":"20","author":"J Hartung","year":"2001","unstructured":"Hartung J, Knapp G. A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat Med. 2001;20(24):3875\u201389. https:\/\/doi.org\/10.1002\/sim.1009.","journal-title":"Stat Med"},{"issue":"6","key":"2298_CR36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989x06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565\u201374. https:\/\/doi.org\/10.1177\/0272989x06295361.","journal-title":"Med Decis Making"},{"key":"2298_CR37","unstructured":"Botan RdN.: CorePAM-Study: CorePAM analytical pipeline. Accessed 2026. https:\/\/github.com\/RafaelBotan\/CorePAM-Study."},{"key":"2298_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the Cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer; 2000."},{"issue":"7","key":"2298_CR39","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/bioinformatics\/btv693","volume":"32","author":"DMA Gendoo","year":"2016","unstructured":"Gendoo DMA, Ratanasirigulchai N, Schr\u00f6der MS, Par\u00e9 L, Parker JS, Prat A, et al. Genefu: an R\/Bioconductor package for computation of gene expression-based signatures in breast cancer. Bioinformatics. 2016;32(7):1097\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btv693.","journal-title":"Bioinformatics"},{"key":"2298_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12916-015-0540-z","volume":"13","author":"A Prat","year":"2015","unstructured":"Prat A, Fan C, Fern\u00e1ndez A, Hoadley KA, Martinello R, Vber M, et al. Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy. BMC Med. 2015;13:303. https:\/\/doi.org\/10.1186\/s12916-015-0540-z.","journal-title":"BMC Med"},{"issue":"22","key":"2298_CR41","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1200\/jco.2012.46.1558","volume":"31","author":"M Dowsett","year":"2013","unstructured":"Dowsett M, Sestak I, Lopez-Knowles E, Sidhu K, Dunbier AK, Cowens JW, et al. Comparison of PAM50 risk of recurrence score with Oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. J Clin Oncol. 2013;31(22):2783\u201390. https:\/\/doi.org\/10.1200\/jco.2012.46.1558.","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02298-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:17:50Z","timestamp":1786663070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02298-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2298"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02298-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8048795\/v1","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study uses exclusively publicly available de-identified data (GEO, GDC, cBioPortal). No new human subjects research was conducted.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"142"}}